Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension: Critical Role for Serotonin-Induced Smooth Muscle Hyperplasia

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Asian Test Symposium

• Publication date

  2006-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.591321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lessons learned from cancer may help in the treatment of pulmonary hypertension.

  2005cited by this paper
• Endothelial/Pericyte Interactions

  2005cited by this paper
• Pulmonary arterial hypertension.

  2004cited by this paper
• Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension

  2004cited by this paper
• Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

  2004cited by this paper
• Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway

  2003cited by this paper
• Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform

  2003cited by this paper
• Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

  2002cited by this paper
• ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells.

  2002cited by this paper
• Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins

  2001cited by this paper
• Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.

  2001cited by this paper
• Primary pulmonary hypertension and anorectic drugs.

  1999cited by this paper
• Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.

  1999cited by this paper
• Clinical economics review: medical management of inflammatory bowel disease

  1999cited by this paper
• Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

  1999cited by this paper
• Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel

  1999cited by this paper
• A new role for an old molecule: serotonin as a mitogen.

  1997cited by this paper
• Signaling Vascular Morphogenesis and Maintenance

  1997cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

  1996cited by this paper
• Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• The Human Tryptophan Hydroxylase Gene

  1995cited by this paper
• Human microvessel endothelial cells: Isolation, culture and characterization

  1993cited by this paper
• Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

  1993cited by this paper
• Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat.

  1992cited by this paper
• Structure and function of the brain serotonin system.

  1992cited by this paper
• Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture.

  1991cited by this paper
• Inhibition of methionine incorporation into brain proteins after the systemic administration of p-chlorophenylalanine and L-5-hydroxytryptophan.

  1991cited by this paper
• Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.

  1990cited by this paper
• Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.

  1988cited by this paper
• Stimulation of aortic smooth muscle cell mitogenesis by serotonin.

  1986cited by this paper
• Estimation of the Rate of Tryptophan Hydroxylation In Vivo: A Sensitive Microassay in Discrete Rat Brain Nuclei

  1980cited by this paper
• p-Chlorophenylalanine: a specific depletor of brain serotonin.

  1966cited by this paper

• 5-Methoxytryptophan attenuates hypobaric hypoxia induced acute lung injury by alleviating lipid peroxidation via targeting peroxiredoxin 6

  2025cites this paper
• Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis.

  2025cites this paper
• Role of inflammation in endothelial responses in Pulmonary Hypertension.

  2025cites this paper
• Important negative trials in pulmonary hypertension.

  2025cites this paper
• New therapies in pulmonary arterial hypertension: Recent insights

  2025cites this paper
• Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension.

  2025cites this paper
• Relationship Between Urine Serotonin and Persistent Pulmonary Hypertension of the Newborn.

  2024cites this paper
• Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.

  2024cites this paper
• Recent developments in connective tissue disease associated pulmonary arterial hypertension

  2024cites this paper
• Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics

  2024cites this paper
• Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression

  2024cites this paper
• Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

  2023cites this paper
• A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension

  2023cites this paper
• Pathogenic Mechanisms of Pulmonary Arterial Hypertension

  2022cites this paper
• Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.

  2022cites this paper
• Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension

  2021cites this paper
• Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

  2021cites this paper
• Sirtuin 3 governs autophagy‐dependent glycolysis during Angiotensin II‐induced endothelial‐to‐mesenchymal transition

  2020cites this paper
• The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease

  2020cites this paper
• Pulmonary hypertension after pneumonectomy: a preclinical model in rats and human pulmonary endothelial cells.

  2020cites this paper
• Metabolism of vascular smooth muscle cells in vascular diseases.

  2020cites this paper
• Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.

  2020cites this paper
• Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558

  2020cites this paper
• Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension

  2020cites this paper
• Extracellular vesicle cross-talk between pulmonary artery smooth muscle cells and endothelium during excessive TGF-β signalling: implications for PAH vascular remodelling

  2019cites this paper
• Phenotype of Mice Lacking Tryptophan Hydroxylase 1

  2019cites this paper
• Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease

  2019cites this paper
• [New insights in the pathogenesis of pulmonary arterial hypertension].

  2019cites this paper
• Inhibition of serotonin synthesis: A novel therapeutic paradigm.

  2019cites this paper
• Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous

  2019cites this paper
• Pulmonary vascular disease and pulmonary hypertension

  2019cites this paper
• Chemerin influences endothelin- and serotonin-induced pulmonary artery vasoconstriction in rats.

  2019cites this paper
• The Role of Sex in the Pathophysiology of Pulmonary Hypertension.

  2018cites this paper
• Peripheral Serotonin Synthesis as a New Drug Target.

  2018influential citation
• Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension

  2018cites this paper
• Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice

  2018cites this paper
• The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease

  2018cites this paper
• Pulmonary vasodilators: Latest evidence and outcomes in the perioperative setting.

  2018cites this paper
• Human Pluripotent Stem Cells to Engineer Blood Vessels.

  2018cites this paper
• FGF21 attenuates hypoxia‑induced dysfunction and apoptosis in HPAECs through alleviating endoplasmic reticulum stress.

  2018cites this paper
• 5‐HT2 and 5‐HT2B antagonists attenuate pro‐fibrotic phenotype in human adult dermal fibroblasts by blocking TGF‐β1 induced non‐canonical signaling pathways including STAT3 : implications for fibrotic diseases like scleroderma

  2018cites this paper
• Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin

  2018cites this paper
• Connexin 43 Plays a Role in Pulmonary Vascular Reactivity in Mice

  2018cites this paper
• Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases.

  2018cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology 5-HT 7 receptor antagonism ( SB-269970 ) attenuates bleomycin-induced pulmonary fi brosis in rats via downregulating oxidative burden and in fl ammatory cascades and ameliorating collagen deposition : Comparison to terguride

  2017cites this paper
• New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways

  2017cites this paper
• Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension.

  2017cites this paper
• Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension

  2017cites this paper
• Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.

  2016cites this paper
• Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.

  2016cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• Growth Factors and Aging in Pulmonary Arterial Hypertension

  2016cites this paper
• Right sided heart failure and pulmonary hypertension: New insights into disease mechanisms and treatment modalities ☆

  2016cites this paper
• RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release.

  2016cites this paper
• with 5-hydroxytryptophan Inhibition of allergic inflammation by supplementation

  2016cites this paper
• [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].

  2016cites this paper
• New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans

  2016cites this paper
• Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors.

  2016cites this paper
• Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.

  2016cites this paper
• Pulmonary arterial hypertension: Basic knowledge for clinicians.

  2016cites this paper
• Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.

  2015cites this paper
• Connexin-mediated regulation of the pulmonary vasculature.

  2015cites this paper
• genes with relevance to human PAH analysis in the pulmonary arteries of mice identifies Serotonin transporter, sex, and hypoxia: microarray

  2015cites this paper
• New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.

  2015cites this paper
• Serotonin in Autism Spectrum Disorder: Insights from Human Studies and Animal Models

  2015cites this paper
• The Pathophysiology, Presentation and Diagnostic Investigation of Pulmonary Hypertension

  2015cites this paper
• Regulation of the norepinephrine transporter by endothelins: a potential therapeutic target.

  2015cites this paper
• Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK

  2015cites this paper
• The influence of gender and sex hormones in the development of translational and experimental pulmonary arterial hypertension

  2014cites this paper
• Upregulation of serotonin-receptor-2a and serotonin transporter expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.

  2014cites this paper
• Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.

  2014cites this paper
• 4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.

  2014cites this paper
• Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

  2014cites this paper
• Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.

  2013cites this paper
• Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.

  2013cites this paper
• Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension

  2013cites this paper
• Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.

  2013cites this paper
• Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.

  2013cites this paper
• The influence of gender on the development of pulmonary arterial hypertension

  2013cites this paper
• The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies

  2013cites this paper
• Serotonin transporter and serotonin receptors.

  2013cites this paper
• mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects

  2013cites this paper
• Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension.

  2013cites this paper
• Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertension.

  2013cites this paper
• Disease Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary

  2013cites this paper
• acute inflammation in mice Platelet serotonin promotes the recruitment of neutrophils to sites of

  2013cites this paper
• Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice.

  2013cites this paper
• [Pathophysiology of pulmonary hypertension: advances and prospects].

  2012cites this paper
• Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

  2012cites this paper
• Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension

  2012cites this paper
• Probing the diversity of serotonin neurons

  2012cites this paper
• An integrative view on the carotid artery alterations in metabolic syndrome

  2012cites this paper
• Hypertension pulmonaire : de la physiopathologie moléculaire aux anomalies hémodynamiques

  2012cites this paper
• Chapter 103 – Smooth Muscle in the Normal and Diseased Pulmonary Circulation

  2012cites this paper
• Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease.

  2011cites this paper
• The Influence of the Major Vasoactive Mediators Relevant to the Pathogenesis of Pulmonary Hypertension

  2011cites this paper
• Key role of the RhoA/Rho kinase system in pulmonary hypertension.

  2011cites this paper
• Role of Endothelium in the Development of Pulmonary Hypertension

  2011cites this paper
• The Serotonin System as a Therapeutic Target in Pulmonary Hypertension

  2011cites this paper
• Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.

  2011cites this paper